I. Roxanis

发表

RIPK1‐mediated immunogenic cell death promotes anti‐tumour immunity against soft‐tissue sarcoma

V. Roulstone, A. Melcher, K. Harrington, 2020, EMBO molecular medicine.

Functionally defined CD164 epitopes are expressed on CD34(+) cells throughout ontogeny but display distinct distribution patterns in adult hematopoietic and nonhematopoietic tissues.

A. Zannettino, J. Lévesque, D. Buck, 2000, Blood.

A case of breast carcinosarcoma with associated myoepitheliosis-like change and morule-like squamous metaplasia. Discussion of possible pathogenetic links

I. Roxanis, 2013 .

A pathogenetic role for the thymoma in myasthenia gravis. Autosensitization of IL-4- producing T cell clones recognizing extracellular acetylcholine receptor epitopes presented by minority class II isotypes.

J. Curnow, A. Vincent, J. Newsom-Davis, 1998, The Journal of clinical investigation.

Thymus, Thymoma, and Specific T Cells in Myasthenia Gravis a

A. Vincent, A. Meager, E. Spack, 1998, Annals of the New York Academy of Sciences.

Thymic myoid cells and germinal center formation in myasthenia gravis; possible roles in pathogenesis

J. Mcconville, J. Newsom-Davis, N. Willcox, 2002, Journal of Neuroimmunology.

Antiangiogenic and tumour inhibitory effects of downregulating tumour endothelial FABP4

A. Harris, U. Harjes, E. Bridges, 2016, Oncogene.

Scenarios for Autoimmunization of T and B Cells in Myasthenia Gravis

J. Todd, A. Vincent, A. Meager, 2003, Annals of the New York Academy of Sciences.

Aberrant Encounter of Acetylcholine Receptor-Expressing Cells with the Lymphoid Infiltrates in the Thymus of Myasthenia Gravis Patients

J. Newsom-Davis, N. Willcox, I. Roxanis, 2000 .

Clinical whole-genome sequencing from routine formalin-fixed, paraffin-embedded specimens: pilot study for the 100,000 Genomes Project

Clare Verrill, Niko Popitsch, Pavlos Antoniou, 2018, Genetics in Medicine.

Recurrent PTPRB and PLCG1 mutations in angiosarcoma

M. Stratton, A. Protopopov, P. Futreal, 2014, Nature Genetics.

Paracrine effect of GTP cyclohydrolase and angiopoietin-1 interaction in stromal fibroblasts on tumor Tie2 activation and breast cancer growth

A. Harris, Wei Zhang, F. Buffa, 2016, Oncotarget.

Integrated Pharmacodynamic Analysis Identifies Two Metabolic Adaption Pathways to Metformin in Breast Cancer

Fergus Gleeson, John D. Fenwick, Fredrik Karpe, 2018, Cell metabolism.

Quantitative Assessment and Prognostic Associations of the Immune Landscape in Ovarian Clear Cell Carcinoma

K. von Loga, M. Hubank, R. Natrajan, 2021, Cancers.

Occurrence and significance of epithelial-mesenchymal transition in breast cancer

I. Roxanis, 2013, Journal of Clinical Pathology.

Rates and Outcomes of Breast Lesions of Uncertain Malignant Potential (B3) benchmarked against the National Breast Screening Pathology Audit; Improving Performance in a High Volume Screening Unit.

A. Joshi, Jasmin Lee, I. Roxanis, 2022, Clinical breast cancer.

3D Functional Genomics Screens Identify CREBBP as a Targetable Driver in Aggressive Triple-Negative Breast Cancer

Gerard P. Quinn, M. Cheang, A. Tutt, 2021, Cancer Research.

Geometric characteristics of collagen have independent prognostic significance in breast ductal carcinoma in situ: an image analysis study

Kylie L. Gorringe, I. Ellis, A. Green, 2019, Modern Pathology.

Thymoma and Autoimmune Neurological Disorders

A. Vincent, D. Beeson, J. Newsom-Davis, 1997 .

Artificial intelligence and digital pathology: Opportunities and implications for immuno-oncology

Yinyin Yuan, N. Somaiah, I. Roxanis, 2021, Biochimica et biophysica acta. Reviews on cancer.

True epithelial hyperplasia in the thymus of early-onset myasthenia gravis patients: implications for immunopathogenesis

N. Willcox, I. Roxanis, K. Micklem, 2001, Journal of Neuroimmunology.

ADGRL4/ELTD1 Expression in Breast Cancer Cells Induces Vascular Normalization and Immune Suppression

A. Harris, A. Banham, E. Bridges, 2021, Molecular Cancer Research.

Assessment of the Molecular Heterogeneity of E-Cadherin Expression in Invasive Lobular Breast Cancer

O. Mariani, A. Vincent-Salomon, R. Natrajan, 2022, Cancers.

Combining lapatinib and pertuzumab to overcome lapatinib resistance due to NRG1-mediated signalling in HER2-amplified breast cancer

A. Harris, Ji-Liang Li, F. Buffa, 2015, Oncotarget.

Metformin increases 18F-FDG flux and inhibits fatty acid oxidation at clinical doses in breast cancer: Results of a phase 0 clinical trial

A. Harris, F. Gleeson, A. Thompson, 2016 .

SuperHistopath: A Deep Learning Pipeline for Mapping Tumor Heterogeneity on Low-Resolution Whole-Slide Digital Histopathology Images

Yinyin Yuan, R. Noguera, Y. Jamin, 2021, Frontiers in Oncology.

Potential of PET to Predict the Response to Trastuzumab Treatment in an ErbB2-Positive Human Xenograft Tumor Model

D. Kiesewetter, J. Capala, G. Kramer-Marek, 2012, The Journal of Nuclear Medicine.

ADAM10 mediates trastuzumab resistance and is correlated with survival in HER2 positive breast cancer

A. Harris, D. Generali, H. Turley, 2014, Oncotarget.

Neratinib overcomes trastuzumab resistance in HER2 amplified breast cancer

M. Duffy, R. Finn, J. Crown, 2013, Oncotarget.

Cellular cohesion as a prognostic factor in malignant melanoma: a retrospective study with up to 12 years follow-up

J. Chow, I. Roxanis, 2010, Modern Pathology.

Capturing global spatial context for accurate cell classification in skin cancer histology pdf

Matthew D. Blackledge, Yinyin Yuan, Ioannis Roxanis, 2018, COMPAY/OMIA@MICCAI.

Superpixel-Based Conditional Random Fields (SuperCRF): Incorporating Global and Local Context for Enhanced Deep Learning in Melanoma Histopathology

Ioannis Roxanis, Henrik Failmezger, Konstantinos Zormpas-Petridis, 2019, Front. Oncol..

Neratinib overcomes trastuzumab resistance in HER2 amplified breast cancer

M. Duffy, R. Finn, J. Crown, 2013, Oncotarget.